Dow Down 0.36% Nasdaq Down 0.53%

More On GLAXF

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

  • Income Statement
  • Balance Sheet
  • Cash Flow

GlaxoSmithKline plc (GLAXF)

-PNK
23.70 Up 0.46(1.98%) Sep 12, 3:51PM EDT
Prev Close:23.24
Open:23.34
Bid:N/A
Ask:N/A
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:23.34 - 23.70
52wk Range:23.20 - 28.56
Volume:4,894
Avg Vol (3m):5,788
Market Cap:113.85B
P/E (ttm):13.47
EPS (ttm):1.76
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Key Statistics

Forward P/E (1 yr):0.23
P/S (ttm):2.79
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :95.59
Quarterly EPS Est (Sep-14) :25.23
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):2.93

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

GlaxoSmithKline plc creates, discovers, develops, manufactures, and markets pharmaceutical products, such as vaccines, over-the-counter medicines, and health-related consumer products worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback